Form4insider filings, from the source

Insider holders · CIK 0001593034

Endo International plc · ENDP

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Paul CampanelliPresident, CEO397,726—397,726Feb 26, 2019 · 5:32 pm ESTForm 4
Rajiv De SilvaPresident & CEO291,69563,315355,010Mar 22, 2016 · 4:10 pm EDTForm 4
Michael HyattDirector279,01510,375289,390Jun 12, 2018 · 4:10 pm EDTForm 4
Roger H KimmelDirector145,277120,000265,277Aug 15, 2018 · 4:22 pm EDTForm 4
Terrance J CoughlinEVP, Chief Operating Officer192,667—192,667Feb 26, 2019 · 5:33 pm ESTForm 4
William P MontagueDirector64,888—64,888Dec 10, 2018 · 4:07 pm ESTForm 4
Shane CookeDirector56,244—56,244Jun 12, 2018 · 4:07 pm EDTForm 4
Blaise ColemanEVP, Chief Financial Officer56,029—56,029Feb 26, 2019 · 5:33 pm ESTForm 4
Arthur J HigginsDirector50,623—50,623May 12, 2016 · 1:08 pm EDTForm 4
Matthew Joseph MalettaEVP, Chief Legal Officer50,609—50,609Feb 26, 2019 · 5:34 pm ESTForm 4
Nancy J HutsonDirector49,970—49,970Nov 16, 2018 · 4:03 pm ESTForm 4
William SpenglerDirector48,835—48,835Mar 17, 2016 · 7:03 pm EDTForm 4
Jill D. SmithDirector43,719—43,719Jun 12, 2017 · 9:43 pm EDTForm 4
Sharad MansukaniDirector43,540—43,540Jun 12, 2018 · 4:16 pm EDTForm 4
Caroline B ManogueExec. V.P.,Chief Legal Officer43,100—43,100Apr 9, 2015 · 5:16 pm EDTForm 4
Antonio R PeraPresident, Par Pharmaceutical40,809—40,809Feb 26, 2019 · 5:35 pm ESTForm 4
John DeluccaDirector32,343—32,343Mar 6, 2015 · 4:19 pm ESTForm 4
Brian LortiePresident Branded Pharma24,504—24,504Mar 4, 2016 · 4:45 pm ESTForm 4
Suketu UpadhyayEVP, Chief Financial Officer22,412—22,412Sep 27, 2016 · 4:03 pm EDTForm 4
Patrick A BarryEVP & Chief Commercial Officer20,698—20,698Feb 25, 2019 · 4:46 pm ESTForm 4
Joseph CiaffoniPresident, U.S. Branded Pharma17,452—17,452Aug 18, 2016 · 11:15 am EDTForm 4
Douglas S IngramDirector17,336—17,336Jun 12, 2017 · 9:40 pm EDTForm 4
Daniel RudioSVP, Controller9,669—9,669Feb 27, 2018 · 4:37 pm ESTForm 4
Carrie Ann NicholVP, Controller & CAO6,740—6,740Feb 26, 2019 · 5:34 pm ESTForm 4
Donald W DeGolyerChief Operating Officer,Pharma6,547—6,547Mar 2, 2015 · 5:21 pm ESTForm 4
Susan HallEVP, CSO, Global Head of R&D4,826—4,826Mar 14, 2016 · 5:53 pm EDTForm 4
Hemanth Jacob VarghesePres. International Pharma4,350—4,350May 2, 2016 · 4:46 pm EDTForm 4
Camille FarhatPresident, AMS, Inc.0—0Mar 12, 2015 · 5:25 pm EDTForm 4
Todd Benjamin SisitskyDirector0—0May 5, 2016 · 5:28 pm EDTForm 3

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.